Featured
How much do pharmas earn in Australia?
A report released by the ATO has revealed the total income declared in Australia for all pharmas who brought in at least a hundred million dollars. See the list
Regulation & Legal
HCP bungles trigger updates to two vaccine PIs
Product information updates for two jabs after reports of incorrect preparation and administration, which may result in the recall of patients for re-vaccination
Regulatory & Reimbursement
If you want a broad listing, ask the patients
The PBAC has updated the guidelines for pharmas seeking multi-cancer listings, looking for information beyond the clinical
Regulation & Legal
Troubled $33M drug withdrawn from Australia
Following reports of eight deaths overseas, allegations trial results were manipulated plus regulatory action in the UK and Europe, this drug is coming off the market
Featured
Leader flies a new flag for industry
After 30 years working in innovative medicine companies, the decision for Nikki Lorenz to become a champion of the generics and biosimilars industry was a surprisingly easy one
Regulation & Legal
No fine after 'disparaging a rival' investigation
While this pharma has staved off a potentially hefty fine, it has agreed to a tough, legally binding agreement after an EU antitrust case
Regulatory & Reimbursement
Gene therapy rollout: Australia next in line?
A US company is ramping up its Australian commercialisation efforts for a gene therapy that won the Best Product for Orphan Disease at the 2026 Prix Galien UK Awards
Patients
Advocates fight to keep Richard Scolyer’s vision alive
Exactly one year after the late Professor challenged Australia to bring the same ambition to brain cancer that helped transform advanced melanoma, advocates are back at Parliament House
Featured
Roadblock hits plans to shore up the world's biggest drug
A strategy to protect market share for this oncology juggernaut has run into a major roadblock overseas and the same legal hurdle could hit Australia too
Leadership & People
Aussie GM reveals success secrets in new book
GSK's Australian Country Leader Andrew Thomas tells how being open to 'taking a shot' created a global high-flying career and offers tips on how pharma professionals can get ahead, in a new book called Work Fame
Government & Policy
Fixing kids' medicine access in Australia
A UCB-sponsored report into the failings of paediatric medicine funding was launched in Parliament House today, attended by the heads of the Standing Committee on Health
Awards
Aussie pioneer lands $50K Novo prize
Pioneering contributions to help eliminate malaria has earned this scientist Novo's coveted Young Women in Science Award plus $50K to continue her research
Jobs & Workplace
Why 'job hugging' is risky in pharma
It's been a tough few years in pharma but this Australian recruitment expert warns that staying put in your current role just for job security is riskier than you think
Pipeline & Intellectual Property
Launch on hold pending legal fight
This company has two generics ready to launch but has agreed to hold off ahead of a Full Federal Court hearing scheduled for next year in which a franchise worth $170M will be challenged
Regulation & Legal
J&J fails to exclude influencers in class action notice
A court has ruled the channels to inform the public of a class action against Johnson & Johnson can include influencers in order to reach as many people as possible
Featured
Fresh starts dominate latest job moves
Talent movements across industry include a new role after redundancy, a move to a new country and leaving a company after 18 years
Jobs
Awards
Award-winning campaign drives drug to 34% market share
This agency alongside its pharma client have been awarded Bronze in Health Marketing, a category that finally returned to this year’s Australian Effie Awards
Patients
Parliament House forum targets faster diagnosis
From 10 months to 10 weeks: national forum held at Parliament house looks to slash diagnosis time for juvenile arthritis in Australia
Government & Policy
Aussie kids missing out on cancer trials
New Medicines Australia white paper calls for reforms to open more potentially life-saving cancer trials to Australian children
Government & Policy
Meet the lobbyists shaping pharma's future
A new ranking reveals the lobbying firms most used by pharmaceutical companies to press their case with the Government - with one clearly ahead of the pack
Regulation & Legal
Company dobs itself in for UK Code Breach
This company was found to have breached the Code of Practice after it voluntarily reported improperly disclosed grants worth more than $1.3M made more than four years ago
Jobs & Workplace
Company launches new leadership role
Created to navigate the increasingly complex landscape of public health priorities, Government policy, public funding and the private market
Regulatory & Reimbursement
Pharmas turn up the heat on Novartis
Additional biosimilar brands targeting this lucrative franchise have been approved ahead of the PBAC's meeting next month which will consider them for PBS listing
Regulatory & Reimbursement
Expanded funding for four diabetes drugs
Tens of thousands gain access to diabetes medications after Pharmac expands eligibility for funded treatments
Industry & Companies
Bayer sets challenge for next-gen innovators
STEM students tackle the impact of climate on Australia’s $100 billion agriculture industry and the trajectory of human health
Jobs & Workplace
Who's left? Senior pharma leaders on the move
Three departures including one redundancy as leaders across industry move on, taking decades of company history with them
Leadership & People
So that's where he's gone: GM lands new job
After a significant stretch as one of industry's longest-serving ANZ Country Leaders this former GM has landed a new role
- Pipeline & Intellectual Property Drug dropped over manufacturing issues
- Pipeline & Intellectual Property Peter Mac spin-off starts life with $12M
- Industry & Companies Company cuts ties with reality TV star
- Regulatory & Reimbursement Eczema drug back on PBS listing track
- Awards Why this Awards comeback matters
- Industry & Companies What specialists really think of MSLs
- Industry & Companies 'Totally unacceptable': Pharma slammed by UK watchdog
- Pipeline & Intellectual Property Smaller dose behind bigger profits?
- Industry & Companies CSL raises $2B but it could come at a cost
- Industry & Companies Moderna enters five-year deal with CSIRO